| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen synthase activity, transferring glucose-1-phosphate | 2.34e-05 | 2 | 97 | 2 | GO:0061547 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 3.89e-05 | 14 | 97 | 3 | GO:0008195 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity | 6.98e-05 | 3 | 97 | 2 | GO:0004373 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 1.02e-04 | 19 | 97 | 3 | GO:0042577 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.96e-04 | 417 | 97 | 9 | GO:0140098 | |
| GeneOntologyMolecularFunction | pheromone receptor activity | 3.46e-04 | 6 | 97 | 2 | GO:0016503 | |
| GeneOntologyCellularComponent | endoribonuclease complex | 2.56e-05 | 37 | 97 | 4 | GO:1902555 | |
| GeneOntologyCellularComponent | endonuclease complex | 4.68e-05 | 43 | 97 | 4 | GO:1905348 | |
| GeneOntologyCellularComponent | primary dendrite | 1.27e-04 | 4 | 97 | 2 | GO:0150001 | |
| GeneOntologyCellularComponent | IRE1-TRAF2-ASK1 complex | 1.27e-04 | 4 | 97 | 2 | GO:1990604 | |
| Domain | Glycogen_synth | 2.56e-05 | 2 | 95 | 2 | IPR008631 | |
| Domain | Glycogen_syn | 2.56e-05 | 2 | 95 | 2 | PF05693 | |
| Domain | Ribonuc_2-5A | 7.65e-05 | 3 | 95 | 2 | PF06479 | |
| Domain | KEN | 7.65e-05 | 3 | 95 | 2 | PS51392 | |
| Domain | KEN_dom | 7.65e-05 | 3 | 95 | 2 | IPR010513 | |
| Domain | PQQ | 7.65e-05 | 3 | 95 | 2 | PF01011 | |
| Domain | - | 9.84e-05 | 18 | 95 | 3 | 1.20.144.10 | |
| Domain | acidPPc | 9.84e-05 | 18 | 95 | 3 | SM00014 | |
| Domain | P_Acid_Pase_2/haloperoxidase | 1.36e-04 | 20 | 95 | 3 | IPR000326 | |
| Domain | PAP2 | 1.36e-04 | 20 | 95 | 3 | PF01569 | |
| Domain | PUG | 2.53e-04 | 5 | 95 | 2 | SM00580 | |
| Domain | Vmron_rcpt_1 | 2.53e-04 | 5 | 95 | 2 | IPR004072 | |
| Domain | V1R | 2.53e-04 | 5 | 95 | 2 | PF03402 | |
| Domain | PQQ | 3.79e-04 | 6 | 95 | 2 | SM00564 | |
| Domain | PQQ_beta_propeller_repeat | 3.79e-04 | 6 | 95 | 2 | IPR018391 | |
| Domain | - | 3.79e-04 | 6 | 95 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 3.79e-04 | 6 | 95 | 2 | IPR027295 | |
| Domain | PUB_domain | 3.79e-04 | 6 | 95 | 2 | IPR018997 | |
| Domain | PQQ_repeat | 3.79e-04 | 6 | 95 | 2 | IPR002372 | |
| Domain | CUB | 1.98e-03 | 49 | 95 | 3 | PF00431 | |
| Domain | CUB | 2.10e-03 | 50 | 95 | 3 | SM00042 | |
| Domain | - | 2.35e-03 | 52 | 95 | 3 | 2.60.120.290 | |
| Domain | CUB | 2.48e-03 | 53 | 95 | 3 | PS01180 | |
| Domain | CUB_dom | 3.06e-03 | 57 | 95 | 3 | IPR000859 | |
| Domain | Channel_four-helix_dom | 3.06e-03 | 57 | 95 | 3 | IPR027359 | |
| Domain | - | 3.06e-03 | 57 | 95 | 3 | 1.20.120.350 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 22315414 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16581782 | ||
| Pubmed | Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis. | 8.02e-06 | 2 | 99 | 2 | 37401737 | |
| Pubmed | Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress. | 8.02e-06 | 2 | 99 | 2 | 11175748 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 27774654 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 12020828 | ||
| Pubmed | RNase domains determine the functional difference between IRE1alpha and IRE1beta. | 8.02e-06 | 2 | 99 | 2 | 18242182 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 36075514 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16950141 | ||
| Pubmed | 1.88e-05 | 55 | 99 | 4 | 29997285 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 11850408 | ||
| Pubmed | Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease. | 2.40e-05 | 3 | 99 | 2 | 30152044 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 10650002 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 29511123 | ||
| Pubmed | FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth. | 2.40e-05 | 3 | 99 | 2 | 37527040 | |
| Pubmed | Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease. | 2.40e-05 | 3 | 99 | 2 | 24452334 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 16973740 | ||
| Pubmed | Cloning of mammalian Ire1 reveals diversity in the ER stress responses. | 2.40e-05 | 3 | 99 | 2 | 9755171 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 30820446 | ||
| Pubmed | The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth. | 2.40e-05 | 3 | 99 | 2 | 36720499 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 18369366 | ||
| Pubmed | 3.80e-05 | 23 | 99 | 3 | 25190801 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 12050113 | ||
| Pubmed | Regulated IRE1-dependent mRNA decay sets the threshold for dendritic cell survival. | 4.79e-05 | 4 | 99 | 2 | 28459443 | |
| Pubmed | Defective ATG16L1-mediated removal of IRE1α drives Crohn's disease-like ileitis. | 4.79e-05 | 4 | 99 | 2 | 28082357 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 20007910 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 18065414 | ||
| Pubmed | AIP1 is critical in transducing IRE1-mediated endoplasmic reticulum stress response. | 4.79e-05 | 4 | 99 | 2 | 18281285 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 24242955 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 38660802 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 5.02e-05 | 139 | 99 | 5 | 16985003 | |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 29897336 | ||
| Pubmed | iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE. | 7.98e-05 | 5 | 99 | 2 | 29897333 | |
| Pubmed | Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis. | 7.98e-05 | 5 | 99 | 2 | 23942232 | |
| Pubmed | Evolutionary deterioration of the vomeronasal pheromone transduction pathway in catarrhine primates. | 7.98e-05 | 5 | 99 | 2 | 12826614 | |
| Pubmed | 8.54e-05 | 493 | 99 | 8 | 15368895 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 26106220 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 32758541 | ||
| Pubmed | Deletion of Pax1 scoliosis-associated regulatory elements leads to a female-biased tail abnormality. | 1.19e-04 | 6 | 99 | 2 | 38461417 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 34622503 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 29776906 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 14680475 | ||
| Pubmed | 1.37e-04 | 35 | 99 | 3 | 22688191 | ||
| Pubmed | Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome. | 1.67e-04 | 7 | 99 | 2 | 38266108 | |
| Pubmed | Identification of a melanoma susceptibility locus and somatic mutation in TET2. | 1.67e-04 | 7 | 99 | 2 | 24980573 | |
| Pubmed | Hepatic glycogen synthesis in the absence of glucokinase: the case of embryonic liver. | 1.67e-04 | 7 | 99 | 2 | 18165236 | |
| Pubmed | Dengue virus modulates the unfolded protein response in a time-dependent manner. | 2.22e-04 | 8 | 99 | 2 | 21385877 | |
| Pubmed | 2.89e-04 | 202 | 99 | 5 | 24639526 | ||
| Pubmed | Identification of G protein-coupled receptor genes from the human genome sequence. | 3.11e-04 | 46 | 99 | 3 | 12044878 | |
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 31006513 | ||
| Pubmed | Human Ccr4-Not complex is a ligand-dependent repressor of nuclear receptor-mediated transcription. | 3.56e-04 | 10 | 99 | 2 | 16778766 | |
| Pubmed | 4.34e-04 | 11 | 99 | 2 | 17572674 | ||
| Pubmed | Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. | 4.73e-04 | 53 | 99 | 3 | 23535033 | |
| Pubmed | 5.20e-04 | 12 | 99 | 2 | 21901158 | ||
| Pubmed | 5.97e-04 | 134 | 99 | 4 | 24324551 | ||
| Pubmed | 6.13e-04 | 13 | 99 | 2 | 22993228 | ||
| Pubmed | 6.13e-04 | 13 | 99 | 2 | 25428889 | ||
| Pubmed | 6.13e-04 | 13 | 99 | 2 | 37070251 | ||
| Pubmed | 6.13e-04 | 13 | 99 | 2 | 34666996 | ||
| Pubmed | Precise Somatotopic Thalamocortical Axon Guidance Depends on LPA-Mediated PRG-2/Radixin Signaling. | 7.14e-04 | 14 | 99 | 2 | 27641493 | |
| Pubmed | 8.22e-04 | 15 | 99 | 2 | 20188150 | ||
| Pubmed | 8.22e-04 | 15 | 99 | 2 | 24453333 | ||
| Pubmed | Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. | 9.38e-04 | 16 | 99 | 2 | 16096065 | |
| Pubmed | 9.55e-04 | 708 | 99 | 8 | 39231216 | ||
| Pubmed | An endoplasmic reticulum stress regulator, Tmbim6, modulates secretory stage of mice molar. | 1.47e-03 | 20 | 99 | 2 | 30963569 | |
| Pubmed | A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. | 1.47e-03 | 20 | 99 | 2 | 35224516 | |
| Pubmed | 1.63e-03 | 21 | 99 | 2 | 25017104 | ||
| Pubmed | 1.68e-03 | 82 | 99 | 3 | 20301334 | ||
| Pubmed | 1.74e-03 | 83 | 99 | 3 | 20562864 | ||
| Pubmed | The imprinted Phlda2 gene regulates extraembryonic energy stores. | 1.79e-03 | 22 | 99 | 2 | 19884348 | |
| Pubmed | 1.79e-03 | 22 | 99 | 2 | 27527664 | ||
| Pubmed | Differential expression and function of ABCG1 and ABCG4 during development and aging. | 1.79e-03 | 22 | 99 | 2 | 19633360 | |
| Pubmed | 1.87e-03 | 85 | 99 | 3 | 23648065 | ||
| Pubmed | 1.95e-03 | 23 | 99 | 2 | 37873566 | ||
| Pubmed | Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners. | 2.01e-03 | 186 | 99 | 4 | 31540324 | |
| Pubmed | The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA. | 2.13e-03 | 24 | 99 | 2 | 24798327 | |
| Pubmed | 2.13e-03 | 24 | 99 | 2 | 25344368 | ||
| Pubmed | HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration. | 2.20e-03 | 90 | 99 | 3 | 35671810 | |
| Pubmed | PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. | 2.20e-03 | 90 | 99 | 3 | 30699358 | |
| Pubmed | Common variants at ten loci influence QT interval duration in the QTGEN Study. | 2.31e-03 | 25 | 99 | 2 | 19305408 | |
| Pubmed | 2.35e-03 | 638 | 99 | 7 | 31182584 | ||
| Pubmed | 2.47e-03 | 197 | 99 | 4 | 31620119 | ||
| Pubmed | MAPK8IP1 FARSB DHX9 SF3B3 PLPPR4 KCND3 HRG ATP1A3 ABLIM2 CNOT1 EXOC4 | 2.53e-03 | 1431 | 99 | 11 | 37142655 | |
| Pubmed | 2.69e-03 | 27 | 99 | 2 | 25133637 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | VN1R2 ZNF154 VRK3 LGALS16 ZNF569 VN1R1 ZNF568 ZSWIM9 ZNF382 GYS1 ATP1A3 | 5.41e-05 | 1192 | 99 | 11 | chr19q13 |
| Cytoband | 19q13.12 | 5.21e-04 | 72 | 99 | 3 | 19q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 6.85e-04 | 183 | 99 | 4 | chr16q22 | |
| GeneFamily | Phospholipid phosphatase related | 1.11e-04 | 5 | 61 | 2 | 1127 | |
| GeneFamily | Glycosyl transferases group 1 domain containing | 4.95e-04 | 10 | 61 | 2 | 427 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 9.39e-04 | 57 | 61 | 3 | 1179 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 1.85e-03 | 19 | 61 | 2 | 132 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.45e-03 | 26 | 61 | 2 | 253 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-06 | 167 | 99 | 6 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-06 | 167 | 99 | 6 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-06 | 167 | 99 | 6 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-06 | 167 | 99 | 6 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 184 | 99 | 6 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 184 | 99 | 6 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.87e-06 | 187 | 99 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.37e-06 | 191 | 99 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.37e-06 | 191 | 99 | 6 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.07e-06 | 196 | 99 | 6 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.07e-06 | 196 | 99 | 6 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.07e-06 | 196 | 99 | 6 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-06 | 199 | 99 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.69e-06 | 200 | 99 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.69e-06 | 200 | 99 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.69e-06 | 200 | 99 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.69e-06 | 200 | 99 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.69e-06 | 200 | 99 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.69e-06 | 200 | 99 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 200 | 99 | 6 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.69e-06 | 200 | 99 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 200 | 99 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.82e-05 | 145 | 99 | 5 | a6c291811bf62f1c13f1b4b396d75c2223cf1c7d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.19e-05 | 163 | 99 | 5 | ce07bc424ef99c547588b07f5c8b39ff0773ca9b | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.79e-05 | 169 | 99 | 5 | e3410ccb3f85811c75694e286115803911169a2f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-05 | 169 | 99 | 5 | a4f610d07c3ba5537f4497f523669b914f7eddc1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 173 | 99 | 5 | 2b448acd5e584f24567204c31b8d74715e92f32a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 173 | 99 | 5 | 5086edc29c5a6137ca09877929a1317f9739c801 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-05 | 175 | 99 | 5 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-05 | 175 | 99 | 5 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-05 | 176 | 99 | 5 | 24eedbbb406d788630bb16678cceef4492d3999c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.12e-05 | 180 | 99 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 180 | 99 | 5 | fa819df81fca95c2cc602fede635cb03e3f35fad | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 180 | 99 | 5 | 907cd510fd2e21532ce04ba687e8894f7af71f27 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.12e-05 | 180 | 99 | 5 | 7d3d5608647b6e684e8e185993d106a38c53e76a | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.25e-05 | 181 | 99 | 5 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.44e-05 | 189 | 99 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 189 | 99 | 5 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 189 | 99 | 5 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 190 | 99 | 5 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 190 | 99 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 190 | 99 | 5 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.77e-05 | 191 | 99 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.77e-05 | 191 | 99 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.77e-05 | 191 | 99 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-05 | 192 | 99 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-05 | 192 | 99 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.94e-05 | 192 | 99 | 5 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.11e-05 | 193 | 99 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 193 | 99 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 7.29e-05 | 194 | 99 | 5 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.29e-05 | 194 | 99 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 7.47e-05 | 195 | 99 | 5 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 196 | 99 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.03e-05 | 198 | 99 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.03e-05 | 198 | 99 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-05 | 198 | 99 | 5 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.03e-05 | 198 | 99 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.03e-05 | 198 | 99 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.03e-05 | 198 | 99 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.03e-05 | 198 | 99 | 5 | 60d8d3bbd754ffde41c50013d822667b185a9751 | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 8.03e-05 | 198 | 99 | 5 | e87d1fe2befbd32b0c723ab43b9de95495ea3ee3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.22e-05 | 199 | 99 | 5 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.22e-05 | 199 | 99 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.22e-05 | 199 | 99 | 5 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.22e-05 | 199 | 99 | 5 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | background-Hepatocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 8.41e-05 | 200 | 99 | 5 | 787d35b5c2f2ad967ae14e99496a0299ac7e72fd | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.41e-05 | 200 | 99 | 5 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-05 | 200 | 99 | 5 | 0cb0755a101ec655359d051d6a8807408d727c55 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.41e-05 | 200 | 99 | 5 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 125 | 99 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 127 | 99 | 4 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | droplet-Liver-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 146 | 99 | 4 | d9df42f8e44018b149a84f07c540cdba74d6374a | |
| ToppCell | droplet-Liver-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 146 | 99 | 4 | a9fa64617c7fb7a66de77360c5642c1da91e465c | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 146 | 99 | 4 | e03658ead410d003e2b18fe94da086a38560b8e7 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 146 | 99 | 4 | 9d7122cc640500c7cd93230df06e331c31625bd5 | |
| ToppCell | droplet-Liver-Npc-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-04 | 148 | 99 | 4 | 4ccf87f3e0d2c61148285979ae92cd41778fa321 | |
| ToppCell | droplet-Liver-Npc-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-04 | 148 | 99 | 4 | 981e205cc8a6f6d2a35dc95c5a93ed9193a236b9 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.39e-04 | 61 | 99 | 3 | 12de8c495c7f47ecd720f29a573471705603732a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.39e-04 | 61 | 99 | 3 | a655232c6d92335eb086723ab9b05eb3a5479b68 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.41e-04 | 149 | 99 | 4 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 152 | 99 | 4 | d5ba87b5d34e52cef8475befafea962d70fa8a1d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 152 | 99 | 4 | d88d68a788a3256671ebbc06e104833f1f58f07d | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 3.86e-04 | 154 | 99 | 4 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | control-B_cell|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.15e-04 | 157 | 99 | 4 | 1269b55f2ef6a493f6116b131cc5cc7b8897d63e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.25e-04 | 158 | 99 | 4 | 1f94622186d8329357fa06785e03eeacf29ab1ce | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-04 | 161 | 99 | 4 | 69f5e759c0925daa37e0177a9cc3154842906bf6 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 4.57e-04 | 161 | 99 | 4 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 163 | 99 | 4 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 163 | 99 | 4 | 61b4e38d7bbbb031100670928e6fd4f7ea23814f | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 163 | 99 | 4 | 0b4d234bdd57d5e991f68942333ca89f70ea28df | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 163 | 99 | 4 | cc728796e52d0e6cc1198e0732370c62380e951d | |
| Drug | AC1NSOIE | 6.57e-06 | 9 | 99 | 3 | CID005313199 | |
| Drug | 1-o-phosphonohex-2-ulose | 7.35e-06 | 29 | 99 | 4 | CID000000481 | |
| Disease | Lafora disease (implicated_via_orthology) | 5.87e-05 | 4 | 93 | 2 | DOID:3534 (implicated_via_orthology) | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 4.17e-04 | 46 | 93 | 3 | EFO_0005325, HP_0012735 | |
| Disease | pathological myopia | 4.28e-04 | 111 | 93 | 4 | EFO_0004207 | |
| Disease | pursuit maintenance gain measurement | 6.30e-04 | 123 | 93 | 4 | EFO_0008433 | |
| Disease | vascular endothelial growth factor measurement | 7.44e-04 | 56 | 93 | 3 | EFO_0004762 | |
| Disease | diverticular disease | 9.20e-04 | 236 | 93 | 5 | EFO_0009959 | |
| Disease | Sinus Node Dysfunction (disorder) | 1.00e-03 | 15 | 93 | 2 | C0428908 | |
| Disease | JT interval | 1.15e-03 | 248 | 93 | 5 | EFO_0007885 | |
| Disease | comparative body size at age 10, self-reported | 2.16e-03 | 420 | 93 | 6 | EFO_0009819 | |
| Disease | triacylglycerol 48:3 measurement | 2.18e-03 | 22 | 93 | 2 | EFO_0010406 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDYQFCYSFRGRPGH | 56 | Q9BV23 | |
| YFPKYGFCEAADQFH | 181 | P07360 | |
| FEIGDFVKYQCHPGY | 2276 | Q96PZ7 | |
| DQLFIPDDCYYHGYV | 101 | Q9UKJ8 | |
| FKAHASFYYPLLCEI | 1796 | Q9Y6D6 | |
| FVRGCHLGVFPSYYE | 496 | P54840 | |
| GLPYCEADYHAKFGI | 196 | Q6H8Q1 | |
| MERLCSDGFAFPHYY | 1 | Q8N2N9 | |
| YAYRPGDEEHCFFLV | 186 | P16066 | |
| HKFFCETNLDAYDPY | 56 | Q8N1B3 | |
| RFYKHNAAFCYKLPD | 131 | Q00796 | |
| DKCYPYRNHICNFFD | 506 | Q8WUJ3 | |
| NFYRTGKLHYPRYEC | 96 | Q9UK17 | |
| FRKYQHFSCYSDPEG | 166 | Q9Y691 | |
| HPNVFGFCRADLFYD | 211 | P04196 | |
| YHFYCPGEAKFKSIN | 1946 | Q5T1H1 | |
| YYDCHFAPEVGGRHA | 31 | P13378 | |
| GKPFDLRIYVCHNEY | 86 | A8MUM7 | |
| FCGYHPKNNKYFGFI | 646 | Q9UQF2 | |
| FYGCAFFHGEVDKPA | 266 | Q9BZ67 | |
| FVEPETKICFKYYHG | 151 | Q76N89 | |
| RYFCTERGPQFHYIA | 576 | Q76MJ5 | |
| FYGCAFFHGEVDKPA | 266 | Q9BZ68 | |
| FFCFEHPREAAIAYQ | 351 | Q9P2D6 | |
| QGFFCHDSAYRKPYP | 41 | Q32ZL2 | |
| FCGPNEIDHYFCDVY | 166 | Q8NGL7 | |
| HYPKFGVSEDCLYLN | 111 | Q6NT32 | |
| VYKAFTYDHSCPEGF | 91 | Q9Y328 | |
| AGPAHALYFACYEKL | 141 | Q96A46 | |
| TYGLYFCGKIEINHF | 161 | Q8NGP4 | |
| YNHIFPLLEKYCGFH | 206 | P00439 | |
| KYQGHCYRHFPDRET | 2326 | P16112 | |
| GYDLDLFCIPNHYAE | 16 | P00492 | |
| FPFCGPRKVYHFYCE | 166 | Q8NHA4 | |
| GFLHYPVFLTACIDY | 106 | Q9UJ42 | |
| FFERDGQPYCEKDYH | 396 | P49023 | |
| YLENKGHRYPCFFNT | 86 | Q969H6 | |
| CRAFDVPKRYFSHFY | 66 | Q9H8P0 | |
| FKLVNFGCDYHQYRD | 261 | A4D1B5 | |
| CFHYLIPLAKEGNYA | 786 | Q96A65 | |
| DFGHCFLKYPYEKTL | 706 | Q4G0P3 | |
| FFLRNKEYVCRGHDY | 1366 | Q8IZD9 | |
| CSHERLFQPYYFHEP | 951 | O75460 | |
| AYNDYVHYIEPCFKG | 331 | Q7Z3S7 | |
| RHCFYGLQPDSEYKI | 971 | Q05707 | |
| VKDFSYPYEHECNPY | 141 | Q9H336 | |
| YDYGAPCHKFDVKQI | 26 | P41597 | |
| RVLGFCHYYLPEEQF | 541 | P13637 | |
| CHYYLPEEQFPKGFA | 546 | P13637 | |
| ETCKVYPLFGHYGRF | 466 | Q86UP6 | |
| FVRGCHLGVFPSYYE | 496 | P13807 | |
| FCLFFYKTHQDDYPL | 956 | O94887 | |
| FDQIYFIFPHCGRKA | 81 | Q9BRP7 | |
| FFCHLCQGYFDGPLY | 11 | Q8TAL6 | |
| EAYCKHKYPEQPGRF | 401 | P19793 | |
| HGYFRDPHCLGEQEY | 1831 | Q01668 | |
| DSIAPFHICYYGRLF | 786 | Q8N1G2 | |
| AFGVYPNVCYHKEKR | 996 | Q08211 | |
| DPTYFKHCRYEPQFS | 221 | O15547 | |
| KIPDGFFAHFYAICE | 521 | Q8NAN2 | |
| LNKLEFYCHPYFQRD | 186 | Q9UBD0 | |
| DKYVSGEFRFRHGYC | 221 | Q9BRS2 | |
| LCRGPSTEYGFYHDF | 151 | Q9BW92 | |
| YRKEHQAYVFLLFCG | 61 | Q96HV5 | |
| PYHRGFYCNDESIKY | 61 | O14495 | |
| RFNEKVQYHGYCPDC | 206 | Q569H4 | |
| HSYQLDYCELAGFPK | 106 | Q8TDN2 | |
| RYEDLCAFYHPGVNG | 171 | P79522 | |
| CYGPHDNQRLFLEYG | 271 | Q9NVD3 | |
| CEPYTDHKGRYHFGF | 31 | Q3SXP7 | |
| DDYHEDGFCQPYRGI | 166 | Q01974 | |
| ERGQYPYHLCFDSFF | 616 | Q96JS3 | |
| HYNFNIYHRCEFKIP | 316 | Q9BSU1 | |
| HLCAVYYNKNPGFEI | 496 | Q9NSD9 | |
| YGFRGCFYPHAFNVK | 306 | Q92989 | |
| FPEFLCDYHYGFCDV | 2106 | A5YKK6 | |
| GYQDDFLLYLDPHYC | 346 | Q86TL0 | |
| YKNHPVDVYCGFLIG | 301 | Q7Z2D5 | |
| CGKAFSDFYYFRNHE | 396 | Q8N8Z8 | |
| FAYYFRPGHLLANAC | 131 | Q86XI8 | |
| EFGKPFYHCASYVVT | 206 | Q3ZCX4 | |
| GYIYCDFFQRADKPH | 431 | Q99797 | |
| LNDTGCKFVFYYHRV | 116 | Q9GZP7 | |
| ILDKYYFLCGQPLHF | 56 | Q9NRS4 | |
| VKPYSCHFCGRGFAY | 376 | Q8N1W2 | |
| ALRYEAFQQGHCYEP | 521 | Q53EL9 | |
| AFQQGHCYEPFVKYG | 526 | Q53EL9 | |
| FRYCPSGKHVAYVEG | 331 | Q8IV63 | |
| CGRDHLSFRSYYFPV | 1156 | Q15393 | |
| QHRFPTGYFSICDRY | 896 | Q8IWR0 | |
| PSRHNLYEYDLFGKC | 131 | Q5MCW4 | |
| FGDSGRLYYCKHCDF | 836 | Q96JM2 | |
| RPYECSECGKFFTYH | 271 | Q13106 | |
| YCAVKGHRGFQFFYL | 176 | Q9H6X4 | |
| NDDNMGPFYYRLHFC | 11 | Q86XD8 | |
| FHCPYCGNNFRRKSY | 296 | Q96SR6 | |
| DDYVHEFCRYGAAEP | 476 | Q13564 | |
| NFQFLEPKYGYFHCK | 216 | A6NP61 | |
| FDNYFGCKFLLYAHR | 156 | Q8NFZ6 | |
| HLFLFKLIYNEYCGP | 606 | Q8IYS2 | |
| DTPQAGYFGLFHYCI | 66 | Q86UP9 |